274 related articles for article (PubMed ID: 21372708)
1. Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain?
McGann PT; Ware RE
Curr Opin Hematol; 2011 May; 18(3):158-65. PubMed ID: 21372708
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: results from the BABY-HUG Phase III Clinical Trial.
McGann PT; Flanagan JM; Howard TA; Dertinger SD; He J; Kulharya AS; Thompson BW; Ware RE;
Pediatr Blood Cancer; 2012 Aug; 59(2):254-7. PubMed ID: 22012708
[TBL] [Abstract][Full Text] [Related]
3. How I use hydroxyurea to treat young patients with sickle cell anemia.
Ware RE
Blood; 2010 Jul; 115(26):5300-11. PubMed ID: 20223921
[TBL] [Abstract][Full Text] [Related]
4. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.
Steinberg MH; Barton F; Castro O; Pegelow CH; Ballas SK; Kutlar A; Orringer E; Bellevue R; Olivieri N; Eckman J; Varma M; Ramirez G; Adler B; Smith W; Carlos T; Ataga K; DeCastro L; Bigelow C; Saunthararajah Y; Telfer M; Vichinsky E; Claster S; Shurin S; Bridges K; Waclawiw M; Bonds D; Terrin M
JAMA; 2003 Apr; 289(13):1645-51. PubMed ID: 12672732
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea therapy for sickle cell anemia.
McGann PT; Ware RE
Expert Opin Drug Saf; 2015; 14(11):1749-58. PubMed ID: 26366626
[TBL] [Abstract][Full Text] [Related]
6. Hydroxycarbamide: clinical aspects.
Ware RE
C R Biol; 2013 Mar; 336(3):177-82. PubMed ID: 23643402
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gaps.
Dong M; Ware RE; Dallmann A; Vinks AA
Pharmacotherapy; 2023 May; 43(5):419-429. PubMed ID: 36928875
[TBL] [Abstract][Full Text] [Related]
8. From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia.
Hankins JS; Aygun B; Nottage K; Thornburg C; Smeltzer MP; Ware RE; Wang WC
Medicine (Baltimore); 2014 Dec; 93(28):e215. PubMed ID: 25526439
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub-Saharan Africa: Rationale and Design of the REACH Trial.
McGann PT; Tshilolo L; Santos B; Tomlinson GA; Stuber S; Latham T; Aygun B; Obaro SK; Olupot-Olupot P; Williams TN; Odame I; Ware RE;
Pediatr Blood Cancer; 2016 Jan; 63(1):98-104. PubMed ID: 26275071
[TBL] [Abstract][Full Text] [Related]
11. Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.
Sheehan VA; Luo Z; Flanagan JM; Howard TA; Thompson BW; Wang WC; Kutlar A; Ware RE;
Am J Hematol; 2013 Jul; 88(7):571-6. PubMed ID: 23606168
[TBL] [Abstract][Full Text] [Related]
12. Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia.
Opoka RO; Ndugwa CM; Latham TS; Lane A; Hume HA; Kasirye P; Hodges JS; Ware RE; John CC
Blood; 2017 Dec; 130(24):2585-2593. PubMed ID: 29051184
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.
Aygun B; Mortier NA; Smeltzer MP; Shulkin BL; Hankins JS; Ware RE
Am J Hematol; 2013 Feb; 88(2):116-9. PubMed ID: 23255310
[TBL] [Abstract][Full Text] [Related]
14. Minireview: Prognostic factors and the response to hydroxurea treatment in sickle cell disease.
Wang WC
Exp Biol Med (Maywood); 2016 Apr; 241(7):730-6. PubMed ID: 27026724
[TBL] [Abstract][Full Text] [Related]
15. Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study.
Lebensburger JD; Miller ST; Howard TH; Casella JF; Brown RC; Lu M; Iyer RV; Sarnaik S; Rogers ZR; Wang WC;
Pediatr Blood Cancer; 2012 Oct; 59(4):675-8. PubMed ID: 22190441
[TBL] [Abstract][Full Text] [Related]
16. Effects of hydroxyurea treatment for patients with hemoglobin SC disease.
Luchtman-Jones L; Pressel S; Hilliard L; Brown RC; Smith MG; Thompson AA; Lee MT; Rothman J; Rogers ZR; Owen W; Imran H; Thornburg C; Kwiatkowski JL; Aygun B; Nelson S; Roberts C; Gauger C; Piccone C; Kalfa T; Alvarez O; Hassell K; Davis BR; Ware RE
Am J Hematol; 2016 Feb; 91(2):238-42. PubMed ID: 26615793
[TBL] [Abstract][Full Text] [Related]
17. Optimizing hydroxyurea therapy for sickle cell anemia.
Ware RE
Hematology Am Soc Hematol Educ Program; 2015; 2015():436-43. PubMed ID: 26637755
[TBL] [Abstract][Full Text] [Related]
18. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy.
Estepp JH; Smeltzer MP; Kang G; Li C; Wang WC; Abrams C; Aygun B; Ware RE; Nottage K; Hankins JS
Am J Hematol; 2017 Dec; 92(12):1333-1339. PubMed ID: 28913922
[TBL] [Abstract][Full Text] [Related]
19. Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia.
Alvarez O; Miller ST; Wang WC; Luo Z; McCarville MB; Schwartz GJ; Thompson B; Howard T; Iyer RV; Rana SR; Rogers ZR; Sarnaik SA; Thornburg CD; Ware RE;
Pediatr Blood Cancer; 2012 Oct; 59(4):668-74. PubMed ID: 22294512
[TBL] [Abstract][Full Text] [Related]
20. Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia.
Koren A; Segal-Kupershmit D; Zalman L; Levin C; Abu Hana M; Palmor H; Luder A; Attias D
Pediatr Hematol Oncol; 1999; 16(3):221-32. PubMed ID: 10326220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
